Incidence and severity of asymptomatic ocular injury in adult and pediatric orbital fractures.


Journal

Orbit (Amsterdam, Netherlands)
ISSN: 1744-5108
Titre abrégé: Orbit
Pays: England
ID NLM: 8301221

Informations de publication

Date de publication:
Jun 2023
Historique:
pmc-release: 01 06 2024
medline: 17 5 2023
pubmed: 9 7 2022
entrez: 8 7 2022
Statut: ppublish

Résumé

To evaluate the incidence of severe ocular injury requiring emergent ophthalmic evaluation in visually asymptomatic patients presenting with orbital fractures. We performed a retrospective chart review of all adult and pediatric orbital fractures between 2012-2022 at a level 1 trauma center. Ocular injuries were categorized into severe, moderate, and mild. We evaluated symptoms, mechanism of injury, visual acuity (VA), and severity of injuries using the Cochran-Armitage and linear-by-linear tests. Of the 2495 cases, 1534 had ophthalmology evaluation. The mean ± standard deviation age was 40.4 ± 20.4 years. Most patients were male (73.1%) and Caucasian (75.9%). The mean time to evaluation was 0.6 ± 2.5 days. 486 (31.7%) were visually symptomatic, 760 (49.5%) were asymptomatic, and 288 (18.8%) were unknown. Of the symptomatic, 135 (27.8%) had severe injuries, 108 (22.2%) had moderate injuries, 216 (44.4%) had mild injuries, and 27 (5.6%) had no injuries. Of the asymptomatic, 67 (8.8%) had severe injuries, 183 (24.1%) had moderate injuries, 468 (61.6%) had mild injuries, and 42 (5.5%) had no injuries. Symptoms correlated with injury severity ( Visually asymptomatic orbital fractures were less likely to have severe ocular injuries; however, many patients were unable to express symptoms. Emergent ophthalmology evaluation should be considered in all patients presenting with orbital fractures, especially patients with visual symptoms or are unable to report symptoms.

Identifiants

pubmed: 35801838
doi: 10.1080/01676830.2022.2095648
pmc: PMC9943542
mid: NIHMS1858000
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

273-278

Subventions

Organisme : NCRR NIH HHS
ID : UL1 RR025764
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000105
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002538
Pays : United States

Auteurs

Tyler Etheridge (T)

Moran Eye Center, University of Utah, Department of Ophthalmology, John A., Salt Lake City, Utah, USA.

Ben J Brintz (BJ)

Department of Internal Medicine, Division of Epidemiology, University of Utah, Salt Lake City, Utah, USA.

Michael S Jensen (MS)

Moran Eye Center, University of Utah, Department of Ophthalmology, John A., Salt Lake City, Utah, USA.

Esteban Peralta (E)

Moran Eye Center, University of Utah, Department of Ophthalmology, John A., Salt Lake City, Utah, USA.

Azraa Ayesha (A)

Moran Eye Center, University of Utah, Department of Ophthalmology, John A., Salt Lake City, Utah, USA.

Abigail Jebaraj (A)

Moran Eye Center, University of Utah, Department of Ophthalmology, John A., Salt Lake City, Utah, USA.

Douglas P Marx (DP)

Moran Eye Center, University of Utah, Department of Ophthalmology, John A., Salt Lake City, Utah, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH